A synchronized lysis circuit (SLC)-enabled EcN strain has been developed to periodically release CD47 nanobody and PD-L1 nanobody when EcN sense the hypoxic, acid and high-lactate signals in tumor microenvironment. Here, CD47 is linked to neoplasm.